Literature DB >> 33987256

A predictive model for postthrombotic syndrome in proximal deep vein thrombosis patients.

Peng Qiu1, Junchao Liu1, Fuzhen Wan2, Yuqian Chen3, Kaichuang Ye1, Jinbao Qin1, Qun Huang1, Xinwu Lu1.   

Abstract

BACKGROUND: Postthrombotic syndrome (PTS) is the most common long-term complication of deep vein thrombosis (DVT). Predictive models for PTS after hospitalized DVT patients, especially those with proximal DVT for whom preventative intervention decisions need to be made, are rare. We aimed to develop and externally validate a clinical predictive model for PTS in patients with proximal DVT.
METHODS: This study was a retrospective, single-center, case-control study. The data used in our model were retrospectively collected from a prospective registry database in which 210 (derivation) and 90 (validation) consecutive patients were first diagnosed with proximal DVT. We developed a nomogram using the multivariate logistic regression model. External validation of our predictive model and previous predictive models in our validation set was assessed by discrimination, calibration, and clinical utility.
RESULTS: Of the 30 candidate predictors, 5 were significantly associated with PTS in our final multivariable model, including the number of signs and symptoms (OR 1.33, 95% CI: 1.17 to 1.53, P<0.001), male sex (OR 1.79, 95% CI: 1.07 to 3.06, P=0.028), varicose vein history (OR 3.02, 95% CI: 1.04 to 7.60, P<0.001), BMI (OR 1.06, 95% CI: 1.00 to 1.12, P=0.052), and chronic DVT (OR 2.66, 95% CI: 1.49 to 4.79, P<0.001). The area under the curve was 0.724 in our predictive model, indicating suitable external performance.
CONCLUSIONS: A simple-to-use nomogram effectively predicts the risk of PTS in patients with proximal DVT. This predictive model may be considered for use in clinical care. 2021 Annals of Translational Medicine. All rights reserved.

Entities:  

Keywords:  Postthrombotic syndrome (PTS); clinical prediction rule; deep vein thrombosis (DVT); logistic models

Year:  2021        PMID: 33987256      PMCID: PMC8105809          DOI: 10.21037/atm-20-3239

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  20 in total

Review 1.  Association between thrombophilia and the post-thrombotic syndrome: a systematic review and meta-analysis.

Authors:  A Rabinovich; J M Cohen; P Prandoni; S R Kahn
Journal:  J Thromb Haemost       Date:  2014-01       Impact factor: 5.824

Review 2.  Best management options for chronic iliac vein stenosis and occlusion.

Authors:  Seshadri Raju
Journal:  J Vasc Surg       Date:  2013-02-20       Impact factor: 4.268

3.  Decision curve analysis.

Authors:  Mark Fitzgerald; Benjamin R Saville; Roger J Lewis
Journal:  JAMA       Date:  2015-01-27       Impact factor: 56.272

4.  Endovascular Management of Deep Vein Thrombosis with Rheolytic Thrombectomy: Final Report of the Prospective Multicenter PEARL (Peripheral Use of AngioJet Rheolytic Thrombectomy with a Variety of Catheter Lengths) Registry.

Authors:  Mark J Garcia; Robert Lookstein; Rahul Malhotra; Ali Amin; Lawrence R Blitz; Daniel A Leung; Eugene J Simoni; Peter A Soukas
Journal:  J Vasc Interv Radiol       Date:  2015-03-29       Impact factor: 3.464

5.  Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report.

Authors:  Clive Kearon; Elie A Akl; Joseph Ornelas; Allen Blaivas; David Jimenez; Henri Bounameaux; Menno Huisman; Christopher S King; Timothy A Morris; Namita Sood; Scott M Stevens; Janine R E Vintch; Philip Wells; Scott C Woller; Lisa Moores
Journal:  Chest       Date:  2016-01-07       Impact factor: 9.410

Review 6.  The postthrombotic syndrome: current evidence and future challenges.

Authors:  A Rabinovich; S R Kahn
Journal:  J Thromb Haemost       Date:  2017-01-23       Impact factor: 5.824

7.  Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial.

Authors:  Tone Enden; Ylva Haig; Nils-Einar Kløw; Carl-Erik Slagsvold; Leiv Sandvik; Waleed Ghanima; Geir Hafsahl; Pål Andre Holme; Lars Olaf Holmen; Anne Mette Njaastad; Gunnar Sandbæk; Per Morten Sandset
Journal:  Lancet       Date:  2011-12-13       Impact factor: 79.321

8.  Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis.

Authors:  Susan R Kahn; Ian Shrier; Jim A Julian; Thierry Ducruet; Louise Arsenault; Marie-José Miron; Andre Roussin; Sylvie Desmarais; France Joyal; Jeannine Kassis; Susan Solymoss; Louis Desjardins; Donna L Lamping; Mira Johri; Jeffrey S Ginsberg
Journal:  Ann Intern Med       Date:  2008-11-18       Impact factor: 25.391

9.  Development of a clinical prediction model for the postthrombotic syndrome in a prospective cohort of patients with proximal deep vein thrombosis.

Authors:  A Rabinovich; T Ducruet; S R Kahn
Journal:  J Thromb Haemost       Date:  2017-12-29       Impact factor: 5.824

10.  Derivation and Validation of a Prediction Model for Risk Stratification of Post-Thrombotic Syndrome in Elderly Patients with a First Deep Vein Thrombosis.

Authors:  Marie Méan; Andreas Limacher; Adriano Alatri; Drahomir Aujesky; Lucia Mazzolai
Journal:  Thromb Haemost       Date:  2018-06-30       Impact factor: 5.249

View more
  3 in total

1.  Effective prediction model for preventing postoperative deep vein thrombosis during bladder cancer treatment.

Authors:  Xing Liu; Abai Xu; Jingwen Huang; Haiyan Shen; Yazhen Liu
Journal:  J Int Med Res       Date:  2022-01       Impact factor: 1.671

2.  A Prediction Model Based on Blood Biomarker for Mortality Risk in Patients with Acute Venous Thromboembolism.

Authors:  Jianjun Jiang; Junshuai Xue; Yang Liu
Journal:  J Inflamm Res       Date:  2022-08-18

3.  Machine learning-based prediction of the post-thrombotic syndrome: Model development and validation study.

Authors:  Tao Yu; Runnan Shen; Guochang You; Lin Lv; Shimao Kang; Xiaoyan Wang; Jiatang Xu; Dongxi Zhu; Zuqi Xia; Junmeng Zheng; Kai Huang
Journal:  Front Cardiovasc Med       Date:  2022-09-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.